This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Aubagio (2014-06-09)

Starting date:
June 9, 2014
Posting date:
July 11, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-40371

Recalled Products

Aubagio

Reason

Some units in this lot are missing the lot number and expiry date on the outer packaging. Inner packaging is not affected.

Depth of distribution

Wholesale and patients. Ontario and Quebec only.

Affected products

Aubagio

DIN, NPN, DIN-HIM
DIN 02416328
Dosage form

Tablets

Strength

Teriflunomide, 14 mg

Lot or serial number

4A86A

Companies
Recalling Firm
Genzyme Canada
2700 Matheson Blvd. East, Suite 800, West Tower
Mississauga
L4W 4V9
CANADA
Marketing Authorization Holder
Genzyme Canada
2700 Matheson Blvd. East, Suite 800, West Tower
Mississauga
L4W 4V9
CANADA

Date modified: